Brief: Scope Fluidics Starts Validation Of BacterOMIC System Under Pre-Registration Trials
01/04/2021 12:32
April 1 (Reuters) - Scope Fluidics SA SCPP.WA :
* UNDER PRE-REGISTRATION TRIALS, STARTS VALIDATION OF
BACTEROMIC
SYSTEM IN EXTERNAL LAB ON CLINICAL SAMPLES
* SEES COMPLETION OF PRE-REGISTRATION TRIALS IN Q2 OR Q3
2021
Source text for Eikon: ID:nEM5Fmsnna
Further company coverage: SCPP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
Brief: Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
Brief: Scope Fluidics Q1 Net Loss At 13.5 Million Zlotys
Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
Brief: Scope Fluidics FY Net Loss At 46.4 Million Zlotys